Uhlmann Price Securities, LLC Bristol Myers Squibb CO Transaction History
Uhlmann Price Securities, LLC
- $140 Billion
- Q2 2025
A detailed history of Uhlmann Price Securities, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Uhlmann Price Securities, LLC holds 6,151 shares of BMY stock, worth $273,965. This represents 0.2% of its overall portfolio holdings.
Number of Shares
6,151
Previous 7,754
20.67%
Holding current value
$273,965
Previous $473 Million
39.78%
% of portfolio
0.2%
Previous 0.35%
Shares
4 transactions
Others Institutions Holding BMY
# of Institutions
2,666Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.68 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.07 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.81 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.22 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.15 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $94.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...